Does OSIMERTINIB Cause Rash vesicular? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Rash vesicular have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.0% of all adverse event reports for OSIMERTINIB.
11
Reports of Rash vesicular with OSIMERTINIB
0.0%
of all OSIMERTINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Rash vesicular From OSIMERTINIB?
Of the 11 reports, 10 (90.9%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Rash vesicular Listed in the Official Label?
Yes, Rash vesicular is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Rash vesicular?
ADALIMUMAB (390)
METHOTREXATE (276)
RITUXIMAB (234)
PREDNISONE (221)
DICLOFENAC (216)
NAPROXEN (210)
SECUKINUMAB (207)
TOCILIZUMAB (204)
INFLIXIMAB (201)
LEFLUNOMIDE (196)
Which OSIMERTINIB Alternatives Have Lower Rash vesicular Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN